Getinge (STO: GETI-B) stock: the official figures
Getinge (Getinge AB (publ)) is listed on Nasdaq Stockholm under the ticker GETI-B and belongs to the health care sector. In fiscal 2025 it reported revenue of SEK 34,969m and a net profit of SEK 2,258m, according to the annual accounts it filed with the regulator.
Identifiers for Getinge: ISIN SE0000202624 · LEI 5493003PZ4F570G3W735.
Fiscal 2025 figures
| Item | 2025 | 2024 | Change |
|---|---|---|---|
| Revenue | SEK 34,969m | SEK 34,759m | +0.6% |
| Operating profit | SEK 3,789m | SEK 2,854m | +32.8% |
| Net profit | SEK 2,258m | SEK 1,638m | +37.9% |
| Earnings per share | SEK 8.29 | SEK 6.01 | +37.9% |
| Operating margin | 10.8% | 8.2% | +2.6 pts |
| Net margin | 6.5% | 4.7% | +1.7 pts |
| Total assets | SEK 56,505m | SEK 63,918m | −11.6% |
| Equity | SEK 29,430m | SEK 33,005m | −10.8% |
| Cash | SEK 3,401m | SEK 2,961m | +14.9% |
| Operating cash flow | SEK 3,949m | SEK 4,577m | −13.7% |
Margins are calculated from the filed figures: operating profit and net profit over revenue.
6 fiscal years
| Fiscal year | Revenue | Operating profit | Net profit | Earnings per share | Document |
|---|---|---|---|---|---|
| 2025 | SEK 34,969m | SEK 3,789m | SEK 2,258m | SEK 8.29 | Annual report |
| 2024 | SEK 34,759m | SEK 2,854m | SEK 1,638m | SEK 6.01 | Annual report |
| 2023 | SEK 31,827m | SEK 3,736m | SEK 2,412m | SEK 8.86 | Annual report |
| 2022 | SEK 28,292m | SEK 3,626m | SEK 2,491m | SEK 9.15 | Annual report |
| 2021 | SEK 27,049m | SEK 4,371m | SEK 2,970m | SEK 10.90 | Annual report |
| 2020 | SEK 29,819m | SEK 4,784m | SEK 3,239m | — | — |
The full income statement, balance sheet and cash flow statement are in the annual accounts of Getinge. Year by year: dividends paid.
Dividends
In fiscal 2025, Getinge paid SEK 1,267m in dividends, 56.1% of its net profit, according to its cash flow statement.
| Fiscal year | Dividends paid | Share of net profit |
|---|---|---|
| 2025 | SEK 1,267m | 56.1% |
| 2024 | SEK 1,227m | 74.9% |
| 2023 | SEK 1,181m | 49.0% |
| 2022 | SEK 1,111m | 44.6% |
| 2021 | SEK 858.0m | 28.9% |
| 2020 | SEK 433.0m | 13.4% |
Cash paid out as dividends during the fiscal year, including dividends to minority shareholders of subsidiaries when the company does not report them separately. It is not the dividend per share.
Frequently asked questions about Getinge
- How much did Getinge earn in fiscal 2025?
- Getinge reported a net profit of SEK 2,258m for fiscal 2025, on revenue of SEK 34,969m. The year before it reported a net profit of SEK 1,638m.
- Does Getinge pay a dividend?
- In fiscal 2025, Getinge paid SEK 1,267m in dividends, 56.1% of its net profit, according to its cash flow statement.
- What are the earnings per share of Getinge?
- They were SEK 8.29 in fiscal 2025, compared with SEK 6.01 the year before.
- Where is Getinge listed?
- Getinge is listed on Nasdaq Stockholm under the ticker GETI-B and belongs to the health care sector.
- What is the ISIN of Getinge?
- The ISIN of Getinge is SE0000202624, the international code that identifies its shares. Its LEI, the legal entity identifier, is 5493003PZ4F570G3W735.
- Where do the figures for Getinge come from?
- From the report Getinge files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
The annual accounts come from the report Getinge files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.